Wisdom from ESCRS presenters and attendees for young ophthalmologists

News
Video

At this year's ESCRS meeting, industry leaders shared advice for young ophthalmologists–and what they wish they'd known earlier in their careers

Earlier this year, Ophthalmology Times Europe spent time in Vienna, Austria, for the annual meeting of the European Society of Cataract and Refractive Surgeons (ESCRS). While there, we asked industry leaders for their insights on their ophthalmology careers. Their wisdom is valuable for young ophthalmologists, longtime practitioners and anyone working in this ever-changing field.

Here's what Greg Kunst, Prof Dr Rohit Shetty, and Dr Dee Stephenson had to say.

Greg Kunst, CEO, Aurion Biotech: This is a very small, boutique industry of deep relationships. The value and importance of building those relationships are critical to success. In other areas of medicine, that's probably less true, but in this area, you know, people people stay for most of their careers. The relationships have allowed innovation to move much faster. I mean, there's the ability for doctors to articulate the challenges they face and for innovators to then try to address those challenges with different solutions. And on the drug, device and diagnostic side, that, that's what makes this industry great. And so that would be the area I would, I would say to people is, make sure you spend time building those relationships.

Prof Dr Rohit Shetty, DNB, FRCS, PhD; Consultant Cornea and Refractive Surgery Chairman, Narayana Nethralaya, Bangalore: Don't expect your medicine to be an extension of your past or present. Your future of medicine is going to be completely different. And the future is out there [on the conference floor]. You go to meetings, to every new booth, every new area, and when you start going there, you pick up on every new aspect of new technologies, which are going to come to your clinic.

Dee Stephenson, MD, FACS; CEO, Stephenson Eye Associates; President, American Board of Eye Surgery: Well, I've been an ophthalmologist for 33 years. And when I made the choice, it was the right choice at the time and I have never looked back. If I had it to do all over I'd still be an ophthalmologist, but–the technology keeps changing and changing and changing. And I have every bell and whistle in my OR, and in my office. So I have a boutique practice, but cutting-edge. And, you know, the technology is just incredible. All I know is that I made the right choice and–and it's been very fulfilling and it's you know, I'm enjoying being an ophthalmologist still today.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
Related Content
© 2025 MJH Life Sciences

All rights reserved.